Doctor profile · Federal record
Dr. PAULINE MIZRACHI, M.D.
Internal Medicine Physician (CMS: INTERNAL MEDICINE) · Student in an Organized Health Care Education/Training Program · NEW HYDE PARK, NY
- NPI 1164761656
- Accepts Medicare
- 14 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2 PRO HEALTH PLZ
NEW HYDE PARK, NY 110421111
(516) 622-6020
Credentials & registration
- NPI registered
- February 2013 — 13 yrs on file
- Profile last updated
- October 13, 2016
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- New York #285964-1
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1164761656. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,537
Distinct HCPCS
10
Medicare allowed
$146,267
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
36415 |
Insertion of needle into vein for collection of blood sample | 383 | 265 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 380 | 225 | $146 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 315 | 243 | $8 | |
80061 |
Blood test, lipids (cholesterol and triglycerides) | 288 | 243 | $13 | |
80053 |
Blood test, comprehensive group of blood chemicals | 287 | 233 | $10 | |
84443 |
Blood test, thyroid stimulating hormone (tsh) | 248 | 222 | $16 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 214 | 214 | $149 | |
83036 |
Hemoglobin a1c level | 153 | 142 | $10 | |
82306 |
Vitamin d-3 level | 151 | 146 | $29 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 141 | 133 | $17 |
In context: peer comparison
Among 31 peers in this city , average services per provider: 143. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$1,117
Transactions
41
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 15 | $392.60 | |
| Amgen Inc. | 4 | $190.57 | |
| GlaxoSmithKline, LLC. | 4 | $159.44 | |
| ABBVIE INC. | 10 | $141.61 | |
| Phathom Pharmaceuticals, Inc. | 1 | $108.19 | |
| Novartis Pharmaceuticals Corporation | 3 | $49.10 | |
| Merck Sharp & Dohme LLC | 1 | $19.68 | |
| Lilly USA, LLC | 1 | $19.02 | |
| AstraZeneca Pharmaceuticals LP | 1 | $18.63 | |
| PFIZER INC. | 1 | $18.06 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,040
Patients
615
Total drug cost
$26,710
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 331 | 101 | $5,027 |
| Amlodipine Besylate | Generic | 285 | 89 | $2,446 |
| Losartan Potassium | Generic | 208 | 61 | $3,089 |
| Rosuvastatin Calcium | Generic | 202 | 59 | $3,148 |
| Levothyroxine Sodium | Generic | 182 | 50 | $3,430 |
| Simvastatin | Generic | 121 | 35 | $1,070 |
| Metformin Hcl | Generic | 110 | 33 | $1,104 |
| Metoprolol Succinate | Generic | 104 | 34 | $1,928 |
| Gabapentin | Generic | 89 | 22 | $948 |
| Hydrochlorothiazide | Generic | 89 | 31 | $716 |